Isao Usui

6.5k total citations · 2 hit papers
103 papers, 4.8k citations indexed

About

Isao Usui is a scholar working on Molecular Biology, Epidemiology and Physiology. According to data from OpenAlex, Isao Usui has authored 103 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 35 papers in Epidemiology and 29 papers in Physiology. Recurrent topics in Isao Usui's work include Adipose Tissue and Metabolism (26 papers), Adipokines, Inflammation, and Metabolic Diseases (24 papers) and Metabolism, Diabetes, and Cancer (24 papers). Isao Usui is often cited by papers focused on Adipose Tissue and Metabolism (26 papers), Adipokines, Inflammation, and Metabolic Diseases (24 papers) and Metabolism, Diabetes, and Cancer (24 papers). Isao Usui collaborates with scholars based in Japan, United States and Hungary. Isao Usui's co-authors include Masashi Kobayashi, Kazuyuki Tobe, Jerrold M. Olefsky, Takeshi Imamura, Shiho Fujisaka, Hiroaki Satoh, Tetsuro Haruta, Masaharu Urakaze, Minoru Iwata and Toshiyasu Sasaoka and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Isao Usui

99 papers receiving 4.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Regulatory Mechanisms for Adipose Tissue M1 and M2 Macrophages in Diet-Induced Obese Mice

2009 586 citations Shiho Fujisaka, Isao Usui et al. profile →
Evaluation of the effects of dapagliflozin, a sodium‐glucose co‐transporter‐2 inhibitor, on hepatic steatosis and fibrosis using transient elastography in patients with type 2 diabetes and non‐alcoholic fatty liver disease

2018 286 citations Kanako Kato, Teruo Jojima et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Isao Usui Japan	35	2.0k	1.7k	1.6k	921	653	103	4.8k
Brice Emanuelli Denmark	20	2.6k 1.3×	1.3k 0.7×	1.8k 1.2×	746 0.8×	671 1.0×	36	5.0k
Xavier Palomer Spain	38	2.4k 1.2×	1.2k 0.7×	1.6k 1.0×	568 0.6×	715 1.1×	87	4.9k
Eun Ju Bae South Korea	28	1.7k 0.8×	1.4k 0.8×	1.4k 0.9×	600 0.7×	664 1.0×	80	4.7k
Sandra Galić Australia	33	3.3k 1.6×	1.6k 0.9×	1.9k 1.2×	734 0.8×	1.1k 1.7×	54	6.0k
Minsheng Yuan United States	7	2.0k 1.0×	2.4k 1.4×	1.8k 1.1×	962 1.0×	673 1.0×	9	5.0k
Ángela M. Valverde Spain	48	4.1k 2.0×	2.2k 1.3×	2.0k 1.3×	1.1k 1.2×	923 1.4×	197	8.0k
Lily Dong United States	41	2.7k 1.3×	2.1k 1.2×	1.7k 1.1×	335 0.4×	506 0.8×	74	5.2k
Saswata Talukdar United States	32	3.2k 1.6×	2.5k 1.4×	2.3k 1.4×	1.1k 1.2×	1.1k 1.6×	48	7.3k
Morgan D. Fullerton Canada	31	2.7k 1.3×	1.3k 0.7×	1.2k 0.8×	707 0.8×	1.0k 1.6×	62	4.6k
Shaodong Guo United States	42	4.9k 2.4×	1.1k 0.6×	1.7k 1.1×	1.1k 1.2×	1.2k 1.9×	92	7.3k

Countries citing papers authored by Isao Usui

Since Specialization

Citations

This map shows the geographic impact of Isao Usui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isao Usui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isao Usui more than expected).

Fields of papers citing papers by Isao Usui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isao Usui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isao Usui. The network helps show where Isao Usui may publish in the future.

Co-authorship network of co-authors of Isao Usui

This figure shows the co-authorship network connecting the top 25 collaborators of Isao Usui. A scholar is included among the top collaborators of Isao Usui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isao Usui. Isao Usui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Aso, Yoshimasa, Toshie Iijima, Teruo Jojima, et al.. (2024). High serum levels of CCL11/Eotaxin-1 are associated with diabetic sensorimotor polyneuropathy and peripheral nerve function but not with cardiac autonomic neuropathy in people with type 2 diabetes. Postgraduate Medicine. 136(3). 318–324. 3 indexed citations

Jojima, Teruo, Masaaki Hashiguchi, Shintaro Sakurai, et al.. (2023). Inhibition of IL-33 signaling ameliorate hepatic fibrosis with decreasing MCP-1 in a mouse model of diabetes and non-alcoholic steatohepatitis; comparison for luseogliflozin, an SGLT2 inhibitor. Journal of Diabetes and its Complications. 38(1). 108650–108650. 9 indexed citations

Usui, Isao, Teruo Jojima, Shiho Fujisaka, et al.. (2022). Increased Number of Mucosal-Associated Invariant T Cells Is Associated with the Inhibition of Nonalcoholic Fatty Liver Disease in High Fat Diet–Fed Mice. International Journal of Molecular Sciences. 23(23). 15309–15309. 2 indexed citations

Ando, Hiromi, Masamitsu Maekawa, Yasuhiro Horibata, et al.. (2022). Transcription of cytochrome P450 46A1 in NIH3T3 cells is negatively regulated by FBS. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1867(6). 159136–159136. 1 indexed citations

Iijima, Toshie, Shintaro Sakurai, Takuya Tomaru, et al.. (2021). Acute effect of add‐on therapy with tofogliflozin, a sodium glucose co‐transporter 2 inhibitor, on 24‐hours glucose profile and glycaemic variability evaluated by continuous glucose monitoring in patients with type 2 diabetes receiving dipeptidyl peptidase‐4 inhibitors. International Journal of Clinical Practice. 75(11). e14732–e14732. 2 indexed citations

Jojima, Teruo, Shintaro Sakurai, Toshie Iijima, et al.. (2021). Empagliflozin increases plasma levels of campesterol, a marker of cholesterol absorption, in patients with type 2 diabetes: Association with a slight increase in high-density lipoprotein cholesterol. International Journal of Cardiology. 331. 243–248. 19 indexed citations

Jojima, Teruo, Takahiko Kogai, Toshie Iijima, et al.. (2020). A case of hypoparathyroidism, deafness, and renal dysplasia (HDR) syndrome with a novel frameshift variant in GATA3, p.W10Cfs40, lacks kidney malformation. SHILAP Revista de lepidopterología. 8(12). 2619–2624. 3 indexed citations

Kanasaki, Keizo, Kyoko Nitta, Yuka Nakamura, et al.. (2020). CD‐1^db/db mice: A novel type 2 diabetic mouse model with progressive kidney fibrosis. Journal of Diabetes Investigation. 11(6). 1470–1481. 8 indexed citations

Iijima, Toshie, Shintaro Sakurai, Teruo Jojima, et al.. (2020). Bullous pemphigoid associated with dipeptidyl peptidase‐4 inhibitor showing unfavorable outcomes despite immediate discontinuation of medication. SHILAP Revista de lepidopterología. 8(10). 2007–2012. 3 indexed citations

10.

Iwata, Minoru, Kazuo Hara, Shiho Fujisaka, et al.. (2018). Ratio of low molecular weight serum adiponectin to the total adiponectin value is associated with type 2 diabetes through its relation to increasing insulin resistance. PLoS ONE. 13(3). e0192609–e0192609. 23 indexed citations

11.

Nawaz, Allah, Tomonobu Kado, Yoshiko Igarashi, et al.. (2017). Adipose tissue-resident macrophages and obesity. 5(3). 57–62. 2 indexed citations

12.

Fujisaka, Shiho, Isao Usui, Allah Nawaz, et al.. (2016). M2 macrophages in metabolism. Diabetology International. 7(4). 342–351. 25 indexed citations

13.

Fujisaka, Shiho, Isao Usui, Masashi Ikutani, et al.. (2013). Adipose tissue hypoxia induces inflammatory M1 polarity of macrophages in an HIF-1α-dependent and HIF-1α-independent manner in obese mice. Diabetologia. 56(6). 1403–1412. 186 indexed citations

14.

Satoh, Hiroaki, Matthew Nguyen, Philip D.G. Miles, et al.. (2004). Adenovirus-mediated chronic “hyper-resistinemia” leads to in vivo insulin resistance in normal rats. Journal of Clinical Investigation. 114(2). 224–231. 214 indexed citations

15.

Usui, Isao, Takeshi Imamura, Hiroaki Satoh, et al.. (2004). GRK2 is an endogenous protein inhibitor of the insulin signaling pathway for glucose transport stimulation. The EMBO Journal. 23(14). 2821–2829. 75 indexed citations

16.

Ueno, Eiichi, Tetsuro Haruta, Tatsuhito Uno, et al.. (2001). Potential Role of Gab1 and Phospholipase C-γ in Osmotic Shock-Induced Glucose Uptake in 3T3-L1 Adipocytes. Hormone and Metabolic Research. 33(7). 402–406. 7 indexed citations

17.

Usui, Isao, Tetsuro Haruta, Minoru Iwata, et al.. (2000). Retinoblastoma Protein Phosphorylation via PI 3-Kinase and mTOR Pathway Regulates Adipocyte Differentiation. Biochemical and Biophysical Research Communications. 275(1). 115–120. 23 indexed citations

18.

Ishihara, Hajime, Toshiyasu Sasaoka, Tsutomu Wada, et al.. (1998). Relative Involvement of Shc Tyrosine 239/240 and Tyrosine 317 on Insulin Induced Mitogenic Signaling in Rat1 Fibroblasts Expressing Insulin Receptors. Biochemical and Biophysical Research Communications. 252(1). 139–144. 19 indexed citations

19.

Takada, Yoshihisa, Yasumitsu Takata, Masanori Iwanishi, et al.. (1996). Effect of glimepiride (HOE 490) on insulin receptors of skeletal muscles from genetically diabetic KK-Ay mouse. European Journal of Pharmacology. 308(2). 205–210. 15 indexed citations

20.

Takata, Yasumitsu, Tetsuro Haruta, Toshiyasu Sasaoka, et al.. (1996). The dominant negative effect of a kinase-defective insulin receptor on insulin-like growth factor-I-stimulated signaling in Rat-1 fibroblasts. Metabolism. 45(12). 1474–1482. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact